CAR-T Therapy

Illustrations

Figure 1: Patient’s T-cells are extracted in a routinary blood test.

Figure 2: A retrovirus with an antitumoral gene is designed.

Figure 3: Patient’s T-cells are infected by the retrovirus and genetically modified to express the antitumoral protein.

Figure 4: Antitumoral T-cells are proliferated in lab.

Figure 5: Patient receives these T-cells, which target and destroy tumor cells.

Use case: Slides for a presentation

Figure 6: Slide 1: CAR-T technology

Figure 7: Slide 2: CAR-T technology